X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8777) 8777
Publication (824) 824
Book Review (324) 324
Newspaper Article (166) 166
Book Chapter (91) 91
Newsletter (74) 74
Book / eBook (47) 47
Magazine Article (32) 32
Conference Proceeding (22) 22
Transcript (22) 22
Reference (7) 7
Trade Publication Article (7) 7
Dissertation (5) 5
Data Set (2) 2
Web Resource (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5172) 5172
animals (3500) 3500
serotonin (3352) 3352
male (3314) 3314
index medicus (3176) 3176
pharmacology & pharmacy (2858) 2858
neurosciences (2443) 2443
female (2293) 2293
serotonin receptor agonists - therapeutic use (2033) 2033
psychiatry (1959) 1959
rats (1593) 1593
adult (1524) 1524
clinical neurology (1494) 1494
migraine disorders - drug therapy (1212) 1212
middle aged (1077) 1077
double-blind (999) 999
mice (923) 923
migraine (898) 898
dose-response relationship, drug (891) 891
dopamine (869) 869
antidepressants (837) 837
treatment outcome (837) 837
serotonin receptor agonists - pharmacology (801) 801
research (764) 764
receptors (750) 750
serotonin - metabolism (737) 737
drug therapy (714) 714
5-ht (646) 646
rats, sprague-dawley (645) 645
brain (643) 643
depression (630) 630
pharmacology (624) 624
serotonin uptake inhibitors - therapeutic use (604) 604
receptors, serotonin - drug effects (601) 601
disease models, animal (585) 585
double-blind method (583) 583
sumatriptan (582) 582
rodents (579) 579
serotonin antagonists - pharmacology (565) 565
sumatriptan - therapeutic use (553) 553
schizophrenia (546) 546
antidepressive agents - therapeutic use (543) 543
aged (527) 527
adolescent (512) 512
care and treatment (500) 500
serotonin receptor agonists - adverse effects (496) 496
time factors (483) 483
anxiety (469) 469
health aspects (467) 467
article (446) 446
efficacy (443) 443
drugs (435) 435
medicine (431) 431
serotonin antagonists - therapeutic use (431) 431
analysis (421) 421
receptors, serotonin - metabolism (417) 417
research article (415) 415
tryptamines (408) 408
indoles - therapeutic use (407) 407
rats, wistar (407) 407
pain (395) 395
receptor (395) 395
headache (391) 391
physiological aspects (375) 375
major depressive disorder (374) 374
placebo-controlled trial (373) 373
serotonin reuptake inhibitors (369) 369
serotonin - pharmacology (366) 366
major depression (364) 364
behavior, animal - drug effects (363) 363
brain - drug effects (363) 363
serotonin receptors (361) 361
neurology (359) 359
serotonin receptor agonists - administration & dosage (355) 355
serotonin uptake inhibitors - pharmacology (350) 350
mental disorders (349) 349
studies (349) 349
rat (345) 345
brain - metabolism (344) 344
mental depression (343) 343
neurons (341) 341
piperazines - pharmacology (340) 340
behavior (337) 337
fluoxetine (337) 337
serotonin uptake inhibitors (337) 337
receptors, serotonin - physiology (336) 336
antipsychotic agents - therapeutic use (333) 333
psychopharmacology (332) 332
clinical trials (325) 325
multidisciplinary sciences (321) 321
drug interactions (317) 317
physiology (317) 317
dosage and administration (316) 316
antidepressive agents - pharmacology (311) 311
risk factors (310) 310
serotonin - physiology (305) 305
tryptamines - therapeutic use (301) 301
medicine, general & internal (296) 296
biochemistry & molecular biology (292) 292
motor activity - drug effects (292) 292
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (33) 33
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Online Resources - Online (3) 3
Gerstein Science - Missing (1) 1
Gerstein Science - Periodical Stacks (1) 1
Knox College (Caven) - Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Patient Education (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8862) 8862
French (80) 80
German (76) 76
Spanish (55) 55
Japanese (45) 45
Russian (26) 26
Polish (14) 14
Hungarian (10) 10
Danish (9) 9
Italian (9) 9
Korean (5) 5
Dutch (4) 4
Serbian (3) 3
Norwegian (2) 2
Portuguese (2) 2
Swedish (2) 2
Turkish (2) 2
Arabic (1) 1
Chinese (1) 1
Czech (1) 1
Finnish (1) 1
Lithuanian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Medicinal Chemistry, ISSN 0022-2623, 06/2015, Volume 58, Issue 20, pp. 7901 - 7912
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2010, Volume 363, Issue 3, pp. 245 - 256
Journal Article
Brain, ISSN 0006-8950, 12/2008, Volume 131, Issue 12, pp. 3380 - 3394
Appearance of dyskinesia is a common problem of long-term l-DOPA treatment in Parkinson's disease patients and represents a major limitation for the... 
Serotonin agonists | Parkinson's disease | MPTP monkeys | L-DOPA | Dyskinesia | Serotonin 5-HT1 Receptor Agonists | Receptors, N-Methyl-D-Aspartate - metabolism | Macaca fascicularis | Motor Activity - drug effects | Dyskinesia, Drug-Induced - prevention & control | Parkinson Disease - drug therapy | Corpus Striatum - metabolism | Antiparkinson Agents - therapeutic use | Parkinsonian Disorders - drug therapy | Female | Parkinson Disease - metabolism | Drug Therapy, Combination | Disease Models, Animal | Pyridines - therapeutic use | Dyskinesia, Drug-Induced - etiology | Drug Evaluation, Preclinical - methods | Pyridines - administration & dosage | Drug Administration Schedule | Levodopa - therapeutic use | Proto-Oncogene Proteins c-fos - metabolism | 8-Hydroxy-2-(di-n-propylamino)tetralin - therapeutic use | Treatment Outcome | Parkinsonian Disorders - chemically induced | Antiparkinson Agents - adverse effects | Serotonin Receptor Agonists - therapeutic use | 8-Hydroxy-2-(di-n-propylamino)tetralin - administration & dosage | Animals | Levodopa - adverse effects | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | Serotonin Receptor Agonists - administration & dosage | Index Medicus | Abridged Index Medicus | monkeys | Neurologi | Clinical Medicine | Neurology | Medical and Health Sciences | Medicin och hälsovetenskap | MPTP | Klinisk medicin
Journal Article
NEURON, ISSN 0896-6273, 09/2007, Volume 55, Issue 5, pp. 712 - 725
Current antidepressants are clinically effective only after several weeks of administration. Here, we show that serotonin(4) (5-HT4) agonists reduce immobility... 
NEURONAL-ACTIVITY | DEPRESSION | IN-VIVO | ELEMENT-BINDING PROTEIN | OLFACTORY BULBECTOMY | ANIMAL-MODEL | RAT-BRAIN | HIPPOCAMPAL NEUROGENESIS | NEUROSCIENCES | CAMP | NUCLEUS-ACCUMBENS | Serotonin 5-HT1 Receptor Agonists | Motor Activity - physiology | Motor Activity - drug effects | Depressive Disorder - drug therapy | Male | Hippocampus - drug effects | Cyclic AMP Response Element-Binding Protein - drug effects | Serotonin 5-HT4 Receptor Agonists | Serotonin Receptor Agonists - pharmacology | Brain - metabolism | Piperidines - pharmacology | Time Factors | Reaction Time - drug effects | Stress, Psychological - metabolism | Antidepressive Agents - pharmacology | Phosphorylation - drug effects | Receptor, Serotonin, 5-HT1A - metabolism | Disease Models, Animal | Aniline Compounds - pharmacology | Stress, Psychological - drug therapy | Brain - physiopathology | Rats | Reaction Time - physiology | Depressive Disorder - metabolism | Rats, Sprague-Dawley | Antidepressive Agents - therapeutic use | Brain - drug effects | Hippocampus - metabolism | Serotonin Receptor Agonists - therapeutic use | Animals | Piperidines - therapeutic use | Depressive Disorder - physiopathology | Serotonin - metabolism | Cyclic AMP Response Element-Binding Protein - metabolism | Receptors, Serotonin, 5-HT4 - metabolism | Aniline Compounds - therapeutic use | Serotonin Uptake Inhibitors - pharmacology | Hippocampus - physiopathology | Stress, Psychological - physiopathology
Journal Article
Neuropharmacology, ISSN 0028-3908, 08/2013, Volume 71, pp. 83 - 97
Serotonin (5-HT) is a neurotransmitter that is involved in many behavioral functions, including the organization of defense, and its putative pathological... 
Fear | Zebrafish | Anxiety | Serotonin | Scototaxis | Geotaxis | 5-HYDROXYTRYPTAMINE RELEASE | RAT | 5-HT1A RECEPTOR ANTAGONISTS | REUPTAKE INHIBITORS | DORSAL RAPHE | ADULT ZEBRAFISH | ELEVATED PLUS-MAZE | T-MAZE | NEUROSCIENCES | IN-VIVO | PHARMACOLOGY & PHARMACY | BRAIN | Anti-Anxiety Agents - administration & dosage | Fenclonine - administration & dosage | Spiro Compounds - therapeutic use | Anxiety - drug therapy | Piperidones - therapeutic use | Serotonin - chemistry | Brain - metabolism | Pyridines - adverse effects | Fenclonine - adverse effects | Behavior, Animal - drug effects | Hyperkinesis - chemically induced | Neurons - metabolism | Serotonin 5-HT1 Receptor Antagonists - administration & dosage | Anti-Anxiety Agents - therapeutic use | Buspirone - therapeutic use | Fluoxetine - adverse effects | Disease Models, Animal | Pyridines - administration & dosage | Nerve Tissue Proteins - agonists | Piperazines - therapeutic use | Piperazines - adverse effects | Extracellular Fluid - drug effects | Brain - drug effects | Serotonin Uptake Inhibitors - administration & dosage | Fluoxetine - administration & dosage | Piperazines - administration & dosage | Fenclonine - therapeutic use | Spiro Compounds - administration & dosage | Piperidones - adverse effects | Hyperkinesis - metabolism | Spiro Compounds - adverse effects | Dose-Response Relationship, Drug | Buspirone - administration & dosage | Protein Isoforms - metabolism | Protein Isoforms - agonists | Anti-Anxiety Agents - adverse effects | Buspirone - adverse effects | Fluoxetine - therapeutic use | Neurons - drug effects | Anxiety - metabolism | Pyridines - therapeutic use | Nerve Tissue Proteins - antagonists & inhibitors | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Serotonin 5-HT1 Receptor Agonists - therapeutic use | Serotonin 5-HT1 Receptor Agonists - adverse effects | Serotonin 5-HT1 Receptor Antagonists - adverse effects | Nerve Tissue Proteins - metabolism | Piperidones - administration & dosage | Extracellular Fluid - metabolism | Serotonin 5-HT1 Receptor Antagonists - therapeutic use | Animals | Serotonin - metabolism | Serotonin 5-HT1 Receptor Agonists - administration & dosage | Anxiety - chemically induced | Protein Isoforms - antagonists & inhibitors | Phenols | Buspirone hydrochloride | Fluoxetine
Journal Article
Journal Article
Journal Article